| Hi, Agen. This year has proven to be a difficult one for venture-backed cybersecurity startups looking for an M&A exit, Crunchbase research finds. And, in a somewhat slow week, a disease-fighting biotech pulls in a nine-figure Series B to continue its work on therapies to treat autoimmune diseases and cancer, while AI darling Anthropic hauls in another big round. The first seven months of the year saw only 34 cyber startups get acquired, putting dealmaking at its slowest pace since 2017. However, a couple of recent, large deals offer a positive indicator of pent-up demand. Related Crunchbase Pro list: M&A Involving VC-Backed Cybersecurity Startups Biotech Abcuro, which develops therapies for the treatment of autoimmune diseases and cancer, led the funding rounds last week with a $155 million Series C. Other sectors taking in nine-digit rounds include fintech, telecom and crypto, as well as artificial intelligence with another big round for AI startup Anthropic. Only 18 of the new unicorns minted in 2023 joined The Crunchbase Unicorn Board after an early-stage funding round. That’s a sharp drop from the prior two years. The number of young startups to hit unicorn status quickly this year would be a lot lower, however, if it weren’t for two letters — AI. Insight Partners is tackling AI investments at three distinct layers: the modern data stack, machine-learning operations and generative AI applications. All told, it adds up to billions in investment to date, with billions more likely to follow. We talked with partner George Mathew about what’s next for the firm. Related Crunchbase Pro list: Insight Partners’ AI Portfolio See our curated list of global private companies that are on the path to achieving unicorn status. This list is updated regularly as companies reach a valuation of $500 million or more but less than $1 billion. | 
No comments:
Post a Comment